Immunitor USA Inc. Publishes Interim Data From Phase IIB Imm01 TB Trial
12/30/2010 6:45:01 AM
Kiev, Ukraine (MMD Newswire) December 28, 2010 -- Immunitor announces publication of interim data from the first half of 120-patient imm01 clinical trial (http://clinicaltrials.gov/ct2/show/NCT01222338). The article entitled "Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB" appeared as e-publication ahead of print in peer-reviewed, high-impact Immunotherapy journal. The link to the abstract of paper is available at http://www.ncbi.nlm.nih.gov/pubmed/21182457.